Recombinant Anti-FcγRIIB × Anti-LPA Bispecific Antibody (Tandem Diabody) (CAT#: TAND-L053)

Recombinant Anti-FcγRIIB × Anti-LPA Bispecific Antibody (Tandem Diabody) is a bispecific fusion protein with four binding sites, two of which bind to antigens of one kind of cells and the other two to the other kind of cells. It was designed for the treatment of thrombus.

Specific Inquiry
  • Size:
  • Conjugation:
  • Datasheet
  • MSDS
  • COA

Specifications

  • Target
  • FcγRIIB & LPA
  • Type
  • Tandem Diabody
  • Species Reactivity
  • Human
  • Target 1
  • FcγRIIB
  • Host Species 1
  • Mouse
  • Target 2
  • LPA
  • Host Species 2
  • Mouse
  • Application
  • FuncS, Promising therapeutic agent
  • Related Disease
  • Thrombus

Target

  • Target 1
  • FcγRIIB
  • Alternative Names
  • FCGR2B; Fc fragment of IgG, low affinity IIb, receptor (CD32); CD32; FCG2; CD32B; FCGR2; IGFR2; low affinity immunoglobulin gamma Fc region receptor II-b; CDw32; fcRII-b; Fc gamma RIIb; fc-gamma-RIIb; fc-gamma RII-b; igG Fc receptor II-b; Fc fragment of I
  • Target 2
  • LPA
  • Alternative Names
  • LP; AK38; APOA

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for TAND-L053. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare